Delivery of the α-emitting radioisotope bismuth-213 to solid tumors via single-chain Fv and diabody molecules

This publication has 20 references indexed in Scilit:

• Monoclonal Antibodies in Cancer Treatment
  BioDrugs, 1999
• Radioimmunotherapy with alpha-emitting nuclides
  European Journal of Nuclear Medicine and Molecular Imaging, 1998
• Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2/neu
  British Journal of Cancer, 1998
• Vascular Targeted Radioimmunotherapy with 213Bi—An α-Particle Emitter
  Nuclear Medicine and Biology, 1998
• Alpha-Emitters for Medical Therapy: Workshop of the United States Department of Energy: Denver, Colorado, May 30-31, 1996
  Radiation Research, 1997
• Radioimmunotherapy of B-Cell Lymphoma with [¹³¹I]Anti-B1 (Anti-CD20) Antibody
  New England Journal of Medicine, 1993
• Antitumor effect of deferoxamine on human hepatocellular carcinoma growing in athymic nude mice
  Cancer, 1992
• Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.
  Proceedings of the National Academy of Sciences, 1988
• Radioimmunotherapy with Alpha-Particle-Emitting Immunoconjugates
  Science, 1988
• Conjugation of antibodies with bifunctional chelating agents: Isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions
  Analytical Biochemistry, 1984